bioRxiv Science⌕ Search

Biology subjects

Lycke, M.

Publications and source records attributed to Lycke, M..

3 recordsLinked to original sources

Reconstituting epiblast-extraembryonic endoderm interactions restores anterior-ventral patterning in stem cell-based embryo models.

During mammalian embryogenesis, reciprocal interactions between the epiblast and extraembryonic endoderm are critical for germ layer specification and body plan development during gastrulation. Gastruloids recapitulate aspects of gastrulation in the absence of extraembryonic cues, resulting in a predominantly posteriorized and dorsalized phenotype with a limited lineage diversity. Here, we establish a modular co-aggregation ("aggregoid") strategy that spatially couples embryonic and extraembryonic endoderm-like cells to reconstruct key interactions in vitro. This drives self-organized anterior-ventral patterning together with the emergence of node- and notochord-like structures, enriched endodermal populations, and increased mesodermal diversity, including cardiopharyngeal lineages and vascular endothelium. Our findings demonstrate that modular engineering of lineage interactions can direct self-organized patterning in stem-cell-based embryo models and provide a versatile framework for generating defined morphotypes.

developmental biology↗

Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models

The development of immune checkpoint inhibitors represents a major breakthrough in cancer therapy. Nevertheless, a substantial number of patients fail to respond to checkpoint pathway blockade. {beta}-catenin is the key transcriptional regulator of WNT/{beta}-catenin signaling. Evidence for {beta}-catenin-mediated immune evasion is found in 13% of all cancers, 42% of primary cutaneous melanoma and a mouse melanoma model. Currently, there are no therapeutic strategies available for targeting WNT/{beta}-catenin signaling to counteract checkpoint inhibitor resistance in melanoma. Here we report that a specific small-molecule tankyrase inhibitor, G007-LK, attenuates WNT/{beta}-catenin and YAP signaling pathways in the syngeneic murine B16-F10 melanoma model enabling sensitivity to anti-PD-1 immune checkpoint therapy. RNA sequencing of 18 tankyrase inhibitor-treated human melanoma cell lines and B16-F10 cells revealed a transcriptional response profile for a subpopulation. This cell line sub-group displayed elevated baseline YAP signaling activity and was susceptible to reduce melanocyte inducing transcription factor (MITF) expression upon tankyrase inhibition.

cancer biology↗

High throughput proteomics identifies 484 high-accuracy plasma protein biomarker signatures for ovarian cancer

Ovarian cancer is usually detected at a late stage with the 5-year survival at only 30-40%. Additional means for early detection and improved diagnosis are acutely needed. To search for novel biomarkers, we compared circulating plasma levels of 981 proteins in patients with ovarian cancer and benign tumours, using the proximity extension assay. A novel combinatorial strategy was developed for identification of multivariate biomarker signatures, resulting in 484 mutually exclusive models out of which 448 did not contain the present biomarker MUCIN-16. The top-ranking model consisted of 14 proteins and had a AUC=0.95, PPV=1.0, sensitivity=0.99 and specificity=1.0 for detection of stage III-IV ovarian cancer in the discovery data, and an AUC=0.89, PPV=0.93, sensitivity=0.89 and specificity=0.95 in the replication data. The novel plasma protein signature could be used to improve the diagnosis of women with adnexal ovarian mass or in screening to identify women that should be referred to specialized examination.

cancer biology↗